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Characterization of inflammatory cells in autoimmune tubulointersti-
tial nephritis in rats. Brown Norway rats immunized with bovine
tubular basement membrane (TBM) antigens develop tubulointerstitial
nephritis. The composition of the inflammatory cell infiltrate was
characterized in kidney tissue sections and cell suspensions obtained
from affected kidneys. Anti-TBM antibody deposition in the kidney
began 8 days after immunization and was followed on days 8 to 10 by C3
deposits and infiltration of polymorphonuclear leukocytes (PMN).
After day 13, the infiltrate became almost exclusively mononuclear in
character. On day 13, the inflammatory mononuclear cells recovered by
Ficoll-Hypaque centrifugation contained 10% Ig cells (B cells), 60%
W3/25 cells (T helper cells), 9% OX8 cells (T suppressor cells), 9%
esterase cells (monocytes/macrophages), 4% renal cells, and 8% other
unidentified cells. Monocytes/macrophages were prominent only at the
latest stages of the disease. The ratio of W3I25 to OX8 cells was
higher in the kidney than in the spleen or peripheral blood. The
sequential accumulation of T cells and then monocytes/macrophages
after an initial antibody, complement, and PMN lesion suggests a role
for the T cells (selective prevalence of the helper T cell population over
that of suppressor T cells) both as inflammatory cells and in progression
and regulation of the subsequent stages of injury.
Caractérisation des cellules inflammatoires dans Ia néphrite tubuloin-
terstitielle autoimmune chez des rats. Des rats Brown Norway immun-
isés avec des antigènes de membrane basale tubulaire bovine (TBM)
développent une néphrite tubulo-interstitielle. La composition de l'infil-
trat cellulaire inflammatoire a été caractérisée dans des coupes de rein
et dans des suspensions cellulaires obtenues a partir des reins malades.
Le dépôt d'anticorps anti-TBM dans le rein commencait 8 jours aprés
l'immunisation et était suivi auxjours 8 a 10 par des dépôts de C3 et une
infiltration de leucocytes polymophonucléaires (PMN). Après le jour
13, l'infiltrat devenait presque exclusivement de caractère mononu-
cléaire. Au jour 13, les cellules mononucidaires inflammatoires récupér-
ées par centrifugation au Ficoll-Hypaque contenaient 10% de cellules
Ig (cellules B), 60% de cellules W3/25 (cellules T helper), 9% de
cellules OX8 (cellules T suppressives), 9% de cetlules estérases
(monocytes/macrophages), 4% de cellules rénales, et 8% d'autres
cellules non identifides. Les monocytes/macrophages prédominaient
seulement aux stades le plus tardifs de la maladie. Le rapport de cellules
W3/25 sur OX8 était plus élevé dans le rein que dans Ia rate ou le
sang peripherique. L'accumulation séquentielle de cellules T puis de
monocytes/macrophages après un anticorps initial, le complement et Ia
lesion PMN suggèrent un role des cellules T (prevalence selective de Ia
population cellulaire helper T sur celle des cellules T suppressives) a Ia
fois comme cellules inflammatoires et dans Ia progression et Ia regula-
tion des stades ultérleurs de Ia lesion.
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We were successful a number of years ago when we used a
fluoresceinated anti-T cell antibody to enumerate the influx of T
cells in tissue sections of rat renal allografts that were rejected
[1]. The current availability of monoclonal antibodies reactive
with T cell subsets offers an opportunity to extend these studies
to characterize the inflammatory infiltrates in renal and other
lesions [2, 31. The intense mononuclear interstitial infiltrate of
Brown Norway (BN) rats immunized with heterologous or
homologous renal basement membranes was chosen for study
[4, 5]. BN rats immunized with bovine (BOV) tubular basement
membrane (TBM) antigens develop tubulointerstitial nephritis
characterized by (1) linear deposits of anti-TBM antibodies, (2)
a transient interstitial infiltration of polymorphonuclear leuko-
cytes (PMN), and thereafter by (3) prominent mononuclear cell
infiltrates [51. Humoral immune responses appear to play a
central role in initiation of this model, with the contribution of
the cellular immune system less well defined [5, 61. Based on
the mononuclear characteristics of the subsequent inflamma-
tory lesion in this model and observations in similar models in
rats and guinea pigs, the cellular immune system including
antibody-dependent cytotoxicity plays a contributory role of as
yet undefined magnitude [4—141.
To determine the nature of the interstitial inflammatory cell
infiltrate occurring in BN rats during the course of this model of
tubulointerstitial nephritis, we used specific monoclonal anti-
bodies reactive with T cells and T cell subsets, an anti-
immunoglobulin reagent to identify B cells, and a histochemical
stain to localize monocytes. The infiltrating cellular compo-
nents were characterized by immunofluoresence at the kidney
tissue section level and in cell suspensions obtained from
affected kidneys, spleen and peripheral blood samples. Samples
obtained sequentially allowed analyses of the appearance of the
different cell types in the initiation and progression of tubuloin-
terstitial nephritis. An immunohistochemical technique for de-
tecting the monoclonal reagents was also evaluated.
Methods
Experimental models. Male BN rats, weighing 140 to 150 g,
were obtained either from our own breeding colony or from
Charles River Breeding Laboratories (Wilmington, Massachu-
setts). BOY TBM antigens were prepared as previously de-
scribed [5], lyophilized and stored at —20°C until used. Thirty-
four BN rats were immunized with 4 mg of lyophilized BOY
TBM in 0.5 ml of phosphate-buffered saline (PBS) in complete
Freund's adjuvant (CFA) containing Mycobacterium tuberculo-
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sis H37 Ra strain (Difco Laboratories, Detroit, Michigan) 4 mgI
animal. The inodulum was divided between the hind footpads
and six to eight intradermal sites in the back. All rats also
received two intradermal injections of 50 tl (1 .8 x io orga-
nisms/mi) of Bordetella pertussis (Difco Laboratories) at the
time of immunization.
Experimental protocol. Two groups of immunized BN rats
and their controls were observed over 4 weeks. Group I
consisted of 16 rats which were nephrectomized unilaterally at
various times during the first 2 weeks of the experiment and
then sequentially sacrificed. The composition of the cellular
infiltrates was determined at the tissue section level and com-
pared to routine histologic study. Four BN rats immunized only
with CFA and Bordetella pertussis were sacrificed at 8, 13, 21,
and 28 days after immunization and used as controls.
Group 2 consisted of 18 rats which were sacrificed in sets of
three each at 8, 10. 13, 15. 21, and 28 days after immunization.
The left kidneys were processed for light and immunofluores-
cence studies to determine the evolution of the disease, while
the right kidneys were used for isolation and characterization of
the interstitial inflammatory cell component. Six untreated rats
and another six rats immunized only with CFA and Bordetella
pertussis were used as controls.
Histoimmunopathology. Kidney tissues were fixed for 18 to
24 hr in Bouin's solution and sections were stained with
periodic-acid Schiff (PAS). The characteristics of the interstitial
inflammatory cell infiltrate, tubular degenerative changes, in-
terstitial fibrosis, and vascular lesions were evaluated.
Direct immunofluorescence studies were performed on ace-
tone-fixed serial cryostat sections of snap-frozen kidney tissue.
Fluorescein isothiocyanate-conjugated rabbit anti-rat IgG and
goat anti-rat C3 were obtained from Cappel Laboratories,
Downington, Pennsylvania. The presence of linear deposits of
IgG and C3 along the TBM was graded from 0 to 3+ (0 being
negative and 3+ maximal intensity).
Serology. Sera obtained on days 5 to 7, 15, 21, and 28 from
group I rats were tested for circulating anti-TBM antibodies in
solid phase radioimmunoassays (RIA) using either particulate
(P) or collagenase solubilized (CS) BN IBM antigens [15].
Characterization of cell infiltrates on tissue sections
Acetone-fixed frozen sections of nephrectomy or autopsy
kidney specimens from rats in group I were used to character-
ize the cellular infiltrate using indirect immunofluorescence,
Reagents to detect T cell and T cell subsets, as well as B cells,
were used. Mouse monoclonal antibodies W31l3, W3/25. and
0X8 (as ascites fluid) were purchased from Pel-Freez Biologi-
cals (Rogers. Arkansas). As shown in functional studies, W3113
antibody reacts with thymocytes, T cells, and neutrophils but
not B cells [161; W3125 antibody binds those T lymphocytes that
mediate graft versus host reaction, mixed lymphocyte reaction
and helper cell activity [16, 17]; and 0X8 antibody labels the
remaining T lymphocytes including those which mediate the
allogenic suppression activity [181. Tissue binding of the mouse
monoclonal reagents was detected with F(ab')2 fragments of
goat anti-mouse lgG (Cappel Laboratories, Downington. Penn-
sylvania), which was depleted of any anti-rat IgG cross-reactiv-
ity by passage over a rat IgG-Sepharose 4B affinity column and
fluoresceinated as described below. The specificity of these
monoclonal reagents was shown in separate experiments using
tissue sections obtained at various points during the immuniza-
tion protocol and controls including normal mouse serum,
normal mouse IgG, and hybridoma-induced ascites fluids con-
taining unrelated antibodies. To detect surface Ig B cells, the
F(ab')2 fragments of a polivalent rabbit antiserum to rat immu-
noglobulins were prepared by pepsin digestion under standard
conditions prior to purification by affinity chromatography [19].
The F(ab')2 fragments of goat antiserum to mouse IgG and
rabbit antiserum to rat immunoglobulins at a concentration of
10 mg/mI were conjugated to fluorescein isothiocyanate (Bio-
quest, Cockeysville, Maryland) by dialysis for 24 hr at 4°C
against 10 volumes of 0.1 mg/mI fluorescein isothiocyanate
dissolved in 0.025 M sodium carbonate buffer, pH 9.6. Free
fluorescein was removed by dialysis, and conjugates, with a
fluorescein:protein ratio of 4 to 5.2, were isolated by DE-52
column chromatography [20].
To supplement the indirect immunofluorescence studies, a
comparative staining procedure was performed utilizing a three-
step immunoperoxidase technique [21]. Biotinylated horse anti-
sera to mouse IgG and horseradish peroxidase-avidin D were
commercially obtained from Vector Laboratories (Burlingame.
California). Briefly, 4-mg thick (acetone-fixed) frozen kidney
sections were incubated with the same dilutions of monoclonal
(W3/13, W3/25, 0X8) antibodies used in the indirect imtnuno-
fluorescence studies (1:50). All sections were incubated further
in sequence with 1:1000 dilution of biotinylated horse antiserum
to mouse IgG and with 5 g/ml of horseradish peroxidase-avidin
D. The final reaction was achieved by incubating the sections
with 3,3'-diaminobenzidine tetrahydrochloride (Sigma Chemi-
cal Co.. St. Louis, Missouri) and hydrogen peroxide.
The presence of monocytes in the interstitial cell infiltrate
was demonstrated on frozen kidney sections stained for non-
specific esterase by the method described by Tucker. Pierre.
and Jordan [22].
Evaluation of the inflammatory interstitial cell infiltrate was
assessed by (1) counting in the kidney tissue sections the
number of labeled lg (B cells), W3/l3 (T cells) and W3/25
OX8 (T cell subsets) and esterase cells (monocytes) per
square millimeter, and (2) determining the percentage of posi-
tively labeled cells in 20 randomly chosen areas of interstitial
infiltration. The ratio of fluorescein-positive cells to the total
number of infiltrating cells was assessed using a x 100 oil
immersion phase-contrast objective for fluorescence and phase
contrast microscopy. The presence of PMN. forming part of the
interstitial cell infiltrate, was semiquantitatively graded from 0
to 3+ in the histologic sections.
Characterization of cells in suspension recovered from kidney
Before harvesting the cells, the right kidney was perfused in
vivo to remove circulating cells. Seventy to 100 ml of minimal
essential medium (MEM) (Grand Island Biological Co.. Grand
Island, New York) was injected via the aorta into the right renal
artery, resulting in its complete blanching. Preliminary studies
using perfused and nonperfused kidneys from control rats
revealed a minor contribution of circulating cells. Renal cell
suspensions were obtained by gently teasing the kidney with
fine forceps. Minced pieces of kidney tissue  I mm3 in size
were pressed gently through a 150-gauge wire screen with a
rubber stopper. The resulting suspension was freed of cellular
aggregates by passage through a nylon filter, and the single cell
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suspension was washed three times. MEM used for harvesting
the cells was supplemented with penicillin G (100 U/mI),
streptomycin (100 jg/ml), gentamycin (25 Lg/mI), L-glutamine
(2 mM), and HEPES (10 mM). The viabilities, estimated by
Trypan Blue exclusion (0.1%), were always 80% or greater.
Smears of the renal cell suspension were stained by Wright's
stain and the percentage of PMN was determined after counting
between 400 to 500 total cells. Mononuclear inflammatory cells
were isolated from the renal cell suspensions by Ficoll-Hy-
paque (specific gravity 1.357) density gradient centrifugation.
The interphase was aspirated, washed three times in MEM and
resuspended to 2 x i07 cells/ml in MEM supplemented with
20% fetal calf serum (MEM-FCS). The viability of resulting
renal mononuclear inflammatory cell suspension was always
between 65 to 75%. Contamination of these isolates by renal
epithelial cells was less than 6%, judged by smears stained with
Wright's stain. Three untreated rats, and three that were
immunized only with adjuvants were used in these experiments
as controls.
For T cells and T cell subsets, 1 to 3 X 106 renal mononuclear
cells in 0.1 ml of MEM-FCS were incubated for 15 mm at 4°C
with 25 d of a 1:100 dilution of W3/13, W3/25 and 0X8
monoclonal antibodies. Cells were washed two times, resus-
pended in 0.1 ml of MEM-FCS, and incubated with fluorescein-
ated F(ab')2 fragments of goat anti-mouse IgG for 15 mm at 4°C.
Cells were washed three times and fixed by the addition of 4%
paraformaldehyde for 8 mm at 4°C. After being washed once,
the cells were resuspended in 0.05 ml of MEM-FCS and
mounted with a coverslip onto a glass slide. Controls substitut-
ing normal mouse IgG for the monoclonal reagents yielded <1%
nonspecifically stained viable cells. For surface Ig, 1 to 3 x 106
cells in 0.1 ml of MEM-FCS were incubated for 15 mm at 4°C
with fluoresceinated F(ab')2 fragments of rabbit anti-rat Ig
serum and further processed as mentioned above. The stained
cells were examined with a Zeiss epifluorescence microscope
fitted with appropriate filters for fluorescein fluorescence. For
monocyte identification, 1 to 3 X 106 cells were stained for
nonspecific esterase as described previously [221. In all experi-
ments, 200 to 300 cells were counted. The percentage of
positive cells was calculated by determining the ratio of fluores-
cein and nonspecific esterase positive cells to total viable cells.
Characterization of cells in peripheral blood and spleen
Pooled peripheral blood mononuclear cells were prepared by
Ficoll-Hypaque sedimentation of heparinized blood taken from
the rats in group 2 24 hr prior to being sacrificed. After the
interphase was aspirated and washed three times in MEM,
mononuclear cells were resuspended to 2 x l07/ml in MEM-
FCS. Viability was >95% in all cases. Smears were prepared
from each sample and enumeration of white blood cells (WBC)
was determined by a manual method using the Unopette
microcollection system (Becton-Dickinson, Rutherford, New
Jersey). Six untreated rats and another six rats immunized only
with the adjuvants were used as controls. Mononuclear cells
were isolated from the spleens obtained 24 hr prior to sacrificing
the group 2 rats. The spleens were minced and passed through a
wire mesh screen and nylon gauze to create single cell suspen-
sion. Mononuclear cells were then recovered by Ficoll-Hy-
paque sedimentation, washed three times in MEM and resus-
pended to 2 x 107/ml in MEM-FCS. Viability was between 80
and 85% in all instances. The cells were stained and evaluated
in the same way described for the renal cell suspension.
Results
Experimental models. Pathologic studies. Immunization with
bovine TBM in adjuvant did not cause mortality during the
period of observation. The findings were confined to the
immunopathologic abnormalities in the kidneys. Macroscopi-
cally, lesions were not seen within the first 7 days after
immunization. Starting on day 8 and with progressive severity
over the following days, the kidneys of all immunized BN rats
became enlarged and swollen. Focal and irregular pallor along
with small subcapsular areas of hemorrhage, cortical atrophy,
and capsular adhesions were common findings. At the end of
week 4, the kidneys were reduced in size and presented a firm
consistency. Kidneys of BN rats in the control groups appeared
normal.
By light microscopic examination, lesions were observed in
all kidneys during week 2 after immunization with BOV TBM.
These were characterized by a focal and irregularly distributed
interstitial inflammatory cell infiltration affecting the cortex and
the outer strip of the medulla. The composition of the infiltrate
varied considerably during the time of the experiment (Fig. 1).
From days 8 to 10, the majority of the interstitial infiltrating
cells were PMN, although these decreased in number over the
subsequent days and were practically absent at the end of week
3 (Fig. 2A). From days 13 to 28, nearly all the infiltrating cells
were identified as mononuclear cells, and particularly where
there was severe tubular damage, multinucleated giant cells
were always present (Fig. 2B). In those areas with severe
interstitial cellular infiltrates, focal necrosis, edema, and tubu-
lar epithelial degenerative changes (hyperchromatic nuclei and
cytoplasm vacuolation) were found. As the disease progressed,
groups of tubules developed atrophic changes as well as promi-
nent peritubular fibrosis. Periglomerular fibrosis and moderate
vascular arteriosclerotic lesions were also observed in the most
severely affected areas of the renal tissue. In some rats, focal
proliferation and mild PMN infiltration with increased mesan-
gial matrix and slight GBM thickening was found in the later
stages of disease. The glomerular lesions may have been related
to ischemia or the immune deposits noted below.
Immunofluorescence studies. From day 8 to 28, all kidneys
from BN rats immunized with BOV-TBM in adjuvants exhibit-
ed binding of rat IgG to the basement membranes of proximal
tubules in a linear fashion (Fig. 2C). Deposits of rat C3 were
observed in a similar pattern but always in a lesser amount.
Fine granular glomerular deposits of IgG and C3 were observed
in a few rats late in the experiment. Faint and segmental
deposits of C3 were found along the TBM in immunized rats
examined before day 8, as well as in the control groups.
Serology. By solid phase radioimmunoassay, anti-TBM anti-
bodies reactive with both P and CS BN TBM antigens were
present at 7 days (Fig. 3). The anti-CS TBM antibodies peaked
at 15 days and then gradually fell. In other experiments, the
anti-CS TBM antibody response appears to correlate best with
the development of tubulointerstitial nephritis [151. The anti-P
TBM antibodies continued to increase during the course of the
experiment, during which the histologic lesion changed from
acute inflammation to fibrosis.
Cell infiltrates in tubulointerstitial nephritis 451
I 5161 7 8 9 10111112113114115116117118I191201211221231241251261271281
Fig. 1. The morphologic evolution of tubuloin-
terstitial nephritis in Brown Norway rats im-
munized with bovine tubular basement mem-
brane antigens in adjuvants in summary for
the first 4 weeks of disease.
Mononuclear cells 1 t:
Polymorphonuclear leukocytes 2
Multinuclear giants cells
Vascular alterations 4 t:
Periglomerular fibrosis 5
Tubular degeneration 6
Tubular atrophy 7
Peritubular fibrosis 8L
Interstitial necrosis 9
Interstitial edema 10 C
I 61 7181
Time, days
Fig. 2. A A striking polymorphonuclear leukocyte interstitial infiltrate in a Brown Norway rat on day 9 after immunization with bovine TBM in
adjuvant. (PAS stain, x400) B On day 20, the interstitial infiltrate almost entirely mononuclear in character in a similarly immunized rat. (PAS
stain, x400) C Circumferential linear deposits of rat IgG present in rats immunized with BOV-TBM after day 8. (Fluoresceinated anti-rat IgG
antibody, x400)
Characterization and quantification of the interstitial cell
infiltrate in the kidney tissue sections
Similar results were obtained when the composition of the
interstitial inflammatory cell infiltrate was evaluated by either
the number of infiltrating cells per square millimeters or the
percentage number of cells per high-power field (20 fields)
utilizing the immunofluorescence and nonspecific esterase
methods (Tables I and 2). The total number of cells identifiable
in the infiltrates (Ig, W3/25, OX8, and nonspecific ester-
ase) varied from 39 to 45% early before day 13, when PMN
which were not enumerated were prominent, to 86% on days 13
to 15 at the peak of the mononuclear infiltration. The predomi-
nant mononuclear cells identified in the interstitial cell infiltrate
were W3/l3 cells (total T cells); the peak was reached between
days 13 and 15 (Fig. 4A). Evaluation of the T cell subsets in the
infiltrate showed that W3I25 cells (T inducer/helper cells) were
always found in a higher quantity than OX8 cells (T suppres-
—my;.
b
452 Mampaso and Wilson
Fig. 3. Circulating anti-particulate (P) Brown Norway tubular basement
membrane (BN TBM) and anti-collagenase solubilized (CS) BN TBM
antibodies detected using separate solid phase radioimmunoassays.
The day 0 values represent the control binding of sera from unimmu-
nized BN rats. The anti-CS TBM antibodies peaked on day 15, while
the anti-P TBM antibodies continued to increase through day 28.
Antibody activity is expressed as counts per minute (cpm), which
relates to the amount of antibody bound per well. Previous studies
suggest that the anti-CS TBM antibodies correlated best with disease
induction [15].
sor/cytotoxic cells) Fig. 4B), with the highest ratio of W3/25/
OX8 being observed between days 25 and 28 of the experi-
ment. Jgf plasma cells with cytoplasmic staining were identi-
fied as part of the interstitial cell infiltrate. Surface Ig cells
were not clearly discernible in the sections and were underesti-
mated compared with the results of the renal cell suspension
studies described in the next section. Both the Ig and W3/13
cells were maximum between days 13 and 15. Only a small
number of esterase cells (monocytes/macrophages) were de-
tected in the interstitial infiltrate (Fig. 4C). The number of
monocytes defined by the nonspecific esterase stain seems to
be underestimated [23], based on previous morphologic obser-
vations [9] and the results of the renal cell suspension studies
described in the next section.
When the immunoperoxidase staining method was used to
identify the surface markers of T cells and T cell subsets, the
cells were difficult to enumerate consistently. The percentage
number of labeled positive cells was lower than those evaluated
by the immunofluorescence method. It is possible that some
technical factors including the sensitivity of the staining meth-
ods utilized as well as the unknown stability of surface cell
antigens might be responsible for these discrepancies.
Characterization and quantification in isolates of renal cell
suspensions
As shown in Table 3, the number of mononuclear inflamma-
tory cells recovered from kidney cell suspensions by Ficoll-
Hypaque centrifugation was much higher in the group of rats
immunized with BOV-TBM and adjuvants than in the control
groups. The total number of cells recovered declined somewhat
as tissue injury developed. The number of PMN found in the
renal cell suspensions was also elevated in the BOV-TBM
immunized group, with the highest percentage values being
observed between days 8 and 10. The percent and staining
characteristics (Fig. 5) of Ficoll-purified renal cell suspensions
are recorded in Table 3. The total number of mononuclear cells
that could be identified varied from 77 to 93% and included 3 to
5% of cells felt to be of renal epithelial origin. W3/l3 cells were
the major cell type found between days 9 and 21. Evaluation of
T cell subsets demonstrated a constant predominance of W3/
25 cells over OX8 cells for the entire duration of the
experiment, with the ratio W3/25/OX8 cells always being
higher than in the control groups. The number of surface Ig
cells (B cells) showed an increase (5 to 10 to 13%) from day 8 to
days 13 to 15, and then declined. Esterase cells increased
sharply by week 3, becoming a prominent cell type identified at
day 28,
Characterization of cells in peripheral blood and spleen
As can be seen in Table 4, and with the only exception being
that of a moderate increase in the absolute number of peripheral
blood lymphocytes in the group of rats immunized only with the
adjuvants, there was little change in the makeup of peripheral
blood mononuclear cells in the control groups. Analysis of the
groups of rats immunized with BOV-TBM and adjuvants dem-
onstrated an elevation in the total number of the peripheral
blood lymphocytes/mm3, although the percentage of lympho-
cytes during the leukocytosis varied, being somewhat de-
creased from controls for days 7 to 9, with a moderate increase
for days 14 through 27. The percentage of circulating W3/l 3 +
cells was elevated with respect to the values encountered in the
control groups. This increase was due mainly to the increase of
the W3/25 cells. This resulted in an increase in the W3/2511
OX8 cell ratio observed from days 9 to 27 of the experiment.
Jgf cells, which were slightly elevated on days 7 and 9, showed
a reduced percentage by day 14. There were no differences in
the number of circulating esterase + cells during the experiment.
There were no differences in the percentages of various
mononuclear cells in the spleen between the adjuvant-treated
and untreated control groups (Table 5). An increased number of
splenic W3/l3 cells were found in the group of rats immunized
with BOV-TBM from days 9 to 27. The increased number of
W3/l3 cells was due to an elevation in the number of the W3/
25 cells subset. The W3/25/OX8 ratios were corresponding-
ly higher when compared with the control groups. Ig cells
which were moderately elevated on day 7 decreased over the
following days to a level lower than the control groups, as seen
for circulating Ig cells. There was little difference in the
number of esterase cells as compared with the control groups.
Discussion
This study was designed to identify the composition of the
interstitial inflammatory cell infiltrate occurring in BN rats with
progressive autoimmune tubulointerstitial nephritis. A combi-
nation of monoclonal antibodies and histochemical staining
techniques were used. Monoclonal antibodies have been used
in humans, mice and rats to identify and enumerate various
immune cell subsets by dissection of the cell surface antigens.
Although most of these studies have been done on cell suspen-
sions obtained either from peripheral blood or lymphoid organs
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Table 1. Characterization of interstitial cell infiltrates
Mean cells sD/mm2 of kidney section'
Number Rat Rat
Day of rats PMN IgG C3 Ig W3/l3 W3I25 OX8 W3/251OX8 Esterase
5to7 4b — — — — — — —
8to9 4 ++ +++ ++ 6±2 47±11 35± 8 18± 5 1.9±0.1 1±0
10 4 +++ +++ ++ 6±1 74±33 51±22 27± 8 1.9±0.4 2±1
13 to 15 6 + +++ + 8 4 183 26 151 26 43 7 3.6 0.9 5 1
16 to 20 5 + +++ 4 1 89 20 76 16 22 3 3.4 0.5 6 1
2lto24 4 — +++ 4±1 111±31 96±25 25±12 4.4±1.8 7±2
25to28 5 — +++ 2±1 87±28 78±28 14± 4 5.5±1.2 13±5
8, 13,
21,28 4d — — — — — — —
—
Abbreviations: BOV-TBM, bovine tubular basement membrane antigens; PMN, polymorphonuclear leukocytes.
a Immunofluorescence study.
b Brown Norway rats immunized with BOV-TBM and adjuvants.
Some segmental staining of TBM of unknown significance was present in control rats.
Brown Norway rats immunized with adjuvants.
Table 2. Characterization of interstitial cell infiltrates
Total Mean percentage of total cells SD/per 20 oil immersion fieldsa
Number number of
Day of rats cellsb Ig W3/l3 W3/25 OX8 W3/25/OX8 Esterase Identified'1
8to9 4c 680±140 4±1 35±4 29±3 11±3 2.6±0.5 1±0 45±6
10 4 710±160 4±1 27±4 24±3 9±3 2.7±0.6 2±1 39±4a
13to15 6 780±200 12±4 65±7 57±6 14±4 4.1±0.4 3±1 86±8
16to20 5 925±285 9±2 44±5 38±4 11±3 3.5±0.5 4±1 62±6
21to24 4 1450±410 2±1 47±5 44±4 9±2 4.9±0.5 6±1 61±7
25to28 5 1610±520 2±1 36±6 35±6 6±2 5.9±0.9 7±2 50±5
a Immunofluorescence study. No interstitial cell infiltrates were seen in the tubular basement membrane immunized rat before day 8 or in the
control rats on days 8, 13, 21, and 28 (Table 1).
b Mean infiltrating cells sD/20 oil immersion fields.
Brown Norway rats immunized with BOV-TBM and adjuvants.
' Cells identified as Ig, W3/25, OX8, and esterase.
Days when polymorphonuclear leukocytes were prominent in infiltrate.
Fig. 4. A Stained cells (arrows) with the W3/13 monoclonal reagent (reactive with T cells) in the interstitium of the kidney of a Brown Norway rat 13
days after immunization with bovine tubular basement membrane antigens in adjuvant. (x400) B The selectivity of the 0X8 monoclonal in
identifying only occasional positive cells (arrows) in a large interstitial infiltrate of a day 15 rat. (x400) C Nonspecific esterase cells (monocytes/
macrophages) (arrows) in the interstitium of a rat 27 days after immunization. (x230)
— r
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Fig. 5. A Phase contrast of two mononutJear
cells recovered from the kidney of a Brown
Norway rat 15 days after immunization with
bovine tubular basement membrane antigens
in adjuvant. B The surface of the upper cell
reactive with the 0X8 monoclonal antibody
and classified as an OX8 (suppressor) T cell.
(x930)
Table 3. Recovery and composition of renal cell suspensions
% of total cells % of Ficoll-purified cells
Num-
ber of Ficoll- W3/1361 Ester- Renal
Group rats Day Total cells recovered PMN purified Ig W3/136 W3/256 OX8 0X86 ase celia Other6
Untreated 3 8, 15,28 1.4 x io 1.5 x iO" 0.5 Q•5a 4 1 4 1 57 5 43 3 20 1 2.9 0.4 6 1 4 1 23 4
Immunized 3
with 3
BOY- 3
TBM 3
and 3
adjuvants 3
8 1.6 x 108 6.0 x io
10 9.0 x io 3.0 x io7
13 l.7x 108±5.5x iO
15 6.5 x io 3.0 x io
21 4.0 x io 3.5 x 106
28 5.2 x io 3.0 x 106
17
3
1 ±0.5
1
18±22.9±0.4 2±05±1
16±23.4±0.3 4±25±19±26.6±0.7 9±24±1
10±25.0±0.5 12±25±1
7 2 6.1 0.8 25 4 4 25±3 7.4±0.7 43±73±2
17 4
12 3
8±2
10 3
13 2
7±1
[3, 16—18, 24—29], monoclonal antibodies have also been used to
identify cells in tissue sections [2, 23, 30—331.
In the current studies, the infiltrating inflammatory cells were
characterized and quantified at the kidney tissue section level
and in cell suspensions from the affected kidneys, and also in
the spleen and peripheral blood. In our situation, identification
of the monoclonal antibodies was easier with immunofluores-
cence staining methods than with immunoperoxidase when
both techniques were compared on frozen sections of kidney
tissue. In addition, some mononuclear cells (Ig B cells and
monocytes/macrophages) were underestimated in tissue sec-
tions compared to results obtained from renal cell suspensions.
The study of cell suspensions from affected kidneys allowed a
comparison in the same rat with values obtained from spleen
cell suspensions and peripheral blood samples.
In the periphery and spleen, the W3/25 and OX8 monoclonals
react with non-overlapping subpopulations of T cells [18]. W31
25 has also been reported to react with some macrophages in
the lymph nodes, peritoneal cavity, and liver [33]. The dissocia-
tion between W3/25 and esterase cells in our study suggests
that different populations of cells were recognized by each
technique. The W3/25 cells have been found to have a helper
or amplifier function in graft versus host reactions, mixed
lymphocyte reactions, elimination of tumors, and in anti-hapten
antibody responses [16, 17, 28, 29, 34]. 0X8 reacts with the T
cells that mediate suppressor and cell-mediated cytotoxicity
[18, 351. The OX8 cells also play a role in graft versus host
disease [29].
As previously reported, anti-TBM antibody deposition begins
in the kidney 8 days after immunization of BN rats with BOy-
TBM antigens in adjuvant, followed through day 10 by C3
deposits and prominent infiltration of PMN [5]. This initial
phase was followed by a prominent mononuclear cell infiltra-
tion and eventual interstitial fibrosis. The mononuclear infil-
Immunized
with
adjuvants 3 8, 15, 28 1.3l08±4.0x107 0.5±0.5 4±1 4±164±4 50±518±52.8±0.34±34±120±3
25±7 5±1 67±5 53±314±2 9±1 62±3 54±4
55±7 10±1 61±4 60±4
45±5 13±2 53±4 50±439±5 8±2 44±4 43±425±4 5±2 39±4 37±5
Abbreviations: BOV-TBM, bovine tubular basement membrane antigens; PMN, polymorphonuclear leukocytes.
a Wright stain.
Cells not identified as Ig, W3I25, 0X86, esterase, or renal cells.
Mean 5D.
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Table 4. Absolute numbers and percentages of mononuclear cells in peripheral blood
Number Lymphocytesb
Group of rats Day Lymphocytes/mm3 % Ig W3/l3 W3/25 OX8 W3I25/0X8 Esterase
Untreated 6 a 14,900 2,500 79 2 20 2 64 5 54 3 15 2 3.6 0.5 1 0.2
Immunized with
adjuvants 6 a 20,100 2,650 76 3 20 2 65 4 56 4 16 2 3.5 0.3 2 0.3
Immunized with
BOV-TBM
and adjuvants 3 7 27,400 4,400 65 3 23C 70 52 20 2.6 2
3 9 37,120 5,300 67 2 22 67 57 14 4.1 1
3 12 32,900 4,630 76 5 15 74 63 14 4.5 1
3 14 33,200 4,100 83 3 8 86 77 15 5.1 1
3 20 30,150 3,200 84 1 16 72 63 14 4.5 3
3 27 28,140 2,800 84 2 18 78 68 16 4.2 2
Abbreviation: BOV-TBM, bovine tubular basement membrane antigens.
a Represents the mean SD of blood samples examined on days 7, 9, 12, 14, 20, and 27.
' Wright stain.
Represents values for a poo1 of three rats.
Table 5. Percentage of mononuclear cells in spleen
Number
Group of rats Day 1g W3/l3 W3/25 OX8 W3/25/OX8 Esterase
Untreated 6 a 44 2 41 2 31 2 11 I 2.8 0.5 5 1
a Represents the mean SD of spleen samples examined on days 7, 9, 12, 14, 20, and 27.
trate was studied with monoclonal antibodies reactive with T
cells and T cell subsets, an anti-immunoglobulin reagent to
identify B cells and a histochemical stain to localize monocytes!
macrophages. Initially, W3/l3 cells (total T cells) were pre-
dominant and after 3 weeks esterase cells (monocytes/macro-
phages) became prominent. Analysis of T cell subsets showed
an increasing W3/25/OX8 ratio in the kidney, spleen and
peripheral blood, indicating a prevalence of the helper T cell
population over that of suppressor T cells. This selective
increase in W3/25 cells was maximum in spleen and peripheral
blood the second week after immunization. This selective
increase in the number of W3/25 cells was associated, during
most of the duration of the experiment, with a relative decrease
in the number of B cells in the spleen and peripheral blood. Of
interest, there was a moderate increase in B cells in the kidney
from days 13 to 20. The percentage of monocytes/macrophages
observed in the spleen and peripheral blood in BN rats with
tubulointerstitial nephritis did not change from control, in
contrast with the elevated number of these cells found in
isolates of cells from the kidney. This suggests that factors at
the target organ level, likely related to the T cell infiltration,
could be responsible for the accumulation of the monocytes!
macrophages. The discrepancies between the number of mono-
cytes/macrophages identified at the kidney tissue section level
and in renal cell suspensions probably relates to technical
factors including the esterase stain which seemed to underesti-
mate the number of positive cells in the tissue sections [23].
PMN, T lymphocytes and monocytes/macrophages each rep-
resent the main cell population at different stages of the disease.
Initially, a process typical of antibody-mediated lesions was
seen when anti-TBM antibodies and complement deposited
along the proximal TBM were followed by a transient infiltra-
tion of PMN [5]. This sequence is typical of lesions produced by
passive administration of antibody such as that seen during the
heterologous phase of experimental antiglomerular basement
membrane antibody-induced glomerulonephritis [361. The suc-
cessful transfer of tubulointerstitial nephritis in the rat and
guinea pig with circulating anti-TBM antibody has supported
the importance of humoral immunity for the expression of the
tubulointerstitial lesions [4, 9, 37]. Our findings demonstrate
that T cells are numerous (with the greater subset of these being
W3/25 cells) in the kidney during the second phase of this
Immunized with
adjuvants
Immunized with
BOV-TBM
and adjuvants
6 a 433 39±2 29±2 11±1 2.6±0.4
3 7 51±4 38±4 33±4 11±2 3.0±0.5
3 9 43±4 45±3 38±3 12±1 3.1±0.6
3 12 38±4 49±3 38±1 14±1 2.7±0.2
3 14 31±2 57±4 51±3 12±2 4.2±0.5
3 20 33±3 54±3 48±4 12±1 4.1±0.3
3 27 35±3 54±3 44±3 13±1 3.3±0.5
5±1
3±1
5±1
6±1
5±1
6±1
6±1
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experimental lesion. This finding suggests that cellular mecha-
nisms may contribute to the nephritogenic immune response in
the tubulointerstitial lesions. The possible role of cellular immu-
nity in this experimental tubulointerstitial nephritis has been
demonstrated previously by the induction of mild inflammatory
interstitial lesions with subcapsular transfer of lymph node and
peritoneal exudate cells from similarly immunized rats [61. In
guinea pigs, the transfer of interstitial lesions with sensitized
cells has not been successful [38]. Sugisaki et al [7] also showed
in a somewhat different lesion that transfer of lymphoid cells
but not of serum from kidney-immunized Lewis donors results
in tubulointerstitial lesions in syngeneic recipient rats. Rats
with subnephritogenic amounts of antiglomerular basement
membrane antibody bound in their glomeruli develop histologic
lesions when given cells sensitized to the foreign immunoglob-
ulin deposits [39]. Also, Neilson and Phillips [1 1—131 demon-
strated in guinea pigs immunized with rabbit tubular antigens
that sensitized lymphocytes can migrate to the kidney as well as
participate directly in cytotoxic reactions or secretion of lym-
phokines. Furthermore, these investigators have also recently
reported that anti-TBM antibodies in their model can function
in antibody-dependent cellular cytotoxicity reactions [141.
Monocytes/macrophages act as accessory cells in immune
responses, participate in T-cell-B-cell cooperation in the pro-
duction of antibodies to thymus-dependent antigens, and inter-
act with T cells in the mediation and expression of cell-mediated
immunity [40—45]. The sequential evolution of monocytes/
macrophages following the prominent T cell influx suggests that
their role as scavenger cells may be influenced and perhaps
directed by the T cells. The finding that experimental antiglo-
merular basement membrane antibody-induced glomerulone-
phritis which has evidence of monocyte/macrophage participa-
tion [46, 47] can be interrupted with an anti-lymphocyte anti-
body supports such a hypothesis [48].
Identification and quantification of inflammatory interstitial
cells in BN rats with tubulointerstitial nephritis has demonstrat-
ed a sequential accumulation of PMN, T lymphocytes, and
monocytes/macrophages in the affected kidney. We have also
shown that T cells, particularly W3I25 cells, are prominent
between days 13 and 21, and probably play an important role in
the development, progression, and regulation of this disease. It
is now necessary to perform functional studies including deple-
tion experiments in vivo and in vitro using the separated helper
and suppressor T cell subsets to establish their exact role in the
sequential development of the inflammatory response in this
autoimmune tubulointerstitial nephritis. These studies will have
relevance to human interstitial nephritis, where infiltrating T
cells have been reported recently [49].
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